Updates are available Correction dated 2023-01-16
Click to view Correction: https://doi.org/10.1186/s12984-022-01120-5
-
Authors
Simmatis, Leif E. R.
Early, Spencer
Moore, Kimberly D.
Appaqaq, Simone
Scott, Stephen H.
-
Funding
Funding for this research was provided by:
Ontario Research Fund (09-112)
Natural Sciences and Engineering Research Council of Canada (Discovery Grant)
GlaxoSmithKline (Chair in Neuroscience)
- License Information
-
More Information
Article History
Received: 2 March 2020
Accepted: 25 June 2020
First Online: 2 July 2020
Change Date: 16 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12984-022-01120-5
Ethics approval and consent to participate
: This study was approved by the Queen’s University Research Ethics Board. All participants provided written consent prior to taking part in the study.
: Not applicable.
: SHS is the co-founder and Chief Scientific Officer of Kinarm (formerly BKIN Technologies), the company that commercializes the robotic technology used in this study. LERS, SE, KM and SA have no competing interest to disclose.
